Want to see KR:001570 full AI Analyst Report?
Top Page
Kum Yang Co., Ltd.
(001570)
Select Model
Select Model
Rating:43Neutral
Price Target:―
Action:N/A
Date:10/28/26
The score is primarily weighed down by weak financial performance—persistent losses, declining revenue in 2025, and a deterioration to negative operating and free cash flow—despite a comparatively manageable leverage position in 2024–2025. Valuation is also constrained by a negative P/E, while technical analysis is neutral due to missing indicator data.
Positive Factors
Manageable Leverage
Debt below equity gives Kum Yang some balance-sheet flexibility while it addresses weak profitability and cash generation. This comparatively manageable leverage can preserve financing capacity and provide more room to execute operational changes than a heavily indebted structure would allow.
Negative Factors
Persistent Losses
Repeated annual losses show that the business has not consistently converted its chemical activities into profits. Deeply negative operating profitability weakens internal funding capacity, limits resilience, and makes any recovery dependent on a sustained improvement in operating performance.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Debt below equity gives Kum Yang some balance-sheet flexibility while it addresses weak profitability and cash generation. This comparatively manageable leverage can preserve financing capacity and provide more room to execute operational changes than a heavily indebted structure would allow.
Read all positive factors
Kum Yang Co., Ltd. (001570) vs. SPDR S&P 500 ETF (SPY)
Market Cap
₩632.04B
Dividend Yield3.34%
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)-0.30
Revenue Growth-43.82%
EPS Growth59.38%
CountryKR
Employees431
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)-1014.51
Shares Outstanding63,967,197
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.33
Price to Sales (P/S)5.92
P/FCF Ratio-10.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kum Yang Co., Ltd. Business Overview & Revenue Model
Company Description
Operating globally and domestically within South Korea, Kumyang Co., Ltd. is a prominent producer and distributor of diverse chemical compounds. Their extensive product line features various blowing agents, including specialized capsule formulatio...
Kum Yang Co., Ltd. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
44
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.00B | 102.78B | 153.73B | 152.03B | 213.14B | 217.72B |
| Gross Profit | 5.48B | 7.01B | 17.90B | 34.71B | 54.36B | 42.37B |
| EBITDA | -18.69B | -25.75B | -98.02B | -21.33B | 13.37B | 16.67B |
| Net Income | -62.89B | -65.80B | -140.11B | -60.36B | -33.31B | 13.33B |
Balance Sheet | ||||||
| Total Assets | 1.22T | 1.22T | 1.26T | 703.47B | 278.60B | 314.83B |
| Cash, Cash Equivalents and Short-Term Investments | 15.97B | 12.46B | 28.15B | 56.30B | 26.28B | 39.14B |
| Total Debt | 318.08B | 315.13B | 314.54B | 338.09B | 113.95B | 139.19B |
| Total Liabilities | 774.35B | 761.49B | 762.40B | 456.93B | 160.84B | 197.42B |
| Stockholders Equity | 446.71B | 458.78B | 489.92B | 195.63B | 117.76B | 117.41B |
Cash Flow | ||||||
| Free Cash Flow | -19.14B | -56.86B | -466.56B | -173.06B | -17.66B | -62.43B |
| Operating Cash Flow | -8.96B | -43.20B | -20.34B | 14.93B | 46.00B | -39.81B |
| Investing Cash Flow | -4.86B | -14.00B | -454.19B | -382.26B | -69.23B | -13.10B |
| Financing Cash Flow | 4.77B | 40.48B | 436.44B | 404.28B | 10.95B | 55.84B |
Kum Yang Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ₩628.48B | 7.03 | ― | 2.66% | 6.80% | 63.38% | |
71 Outperform | ₩463.99B | 10.89 | ― | 2.22% | -1.76% | 48.18% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₩589.27B | 16.69 | ― | 0.12% | 1.20% | ― | |
48 Neutral | ₩634.01B | 16.93 | ― | 1.76% | 1.13% | 1114.83% | |
47 Neutral | ₩524.62B | 86.13 | ― | 3.74% | 2.23% | ― | |
43 Neutral | ₩632.04B | -9.76 | ― | 3.34% | -43.82% | 59.38% |
* General Sector Average
KR:001570
Kum Yang Co., Ltd.
―
―
―
KR:178920
PI Advanced Materials Co., Ltd.
15,800.00
-2,362.90
-13.01%
KR:268280
Miwon Specialty Chemical Co. Ltd.
128,000.00
-10,733.81
-7.74%
KR:298050
HS HYOSUNG ADVANCED MATERIALS
141,900.00
-54,122.22
-27.61%
KR:336370
Solus Advanced Materials Co., Ltd.
8,030.00
-1,437.34
-15.18%
KR:456040
OCI Company Ltd.
58,600.00
-2,200.00
-3.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.